Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $101.67 in the prior trading day, Axsome Therapeutics Inc (NASDAQ: AXSM) closed at $95.65, down -5.92%. In other words, the price has decreased by -$5.92 from its previous closing price. On the day, 1.08 million shares were traded. AXSM stock price reached its highest trading level at $99.565 during the session, while it also had its lowest trading level at $92.5.
Ratios:
Our goal is to gain a better understanding of AXSM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.04 and its Current Ratio is at 2.11. In the meantime, Its Debt-to-Equity ratio is 3.56 whereas as Long-Term Debt/Eq ratio is at 3.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on April 07, 2025, initiated with a Buy rating and assigned the stock a target price of $200.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $176.
Mizuho reiterated its Outperform rating for the stock on December 31, 2024, while the target price for the stock was revised from $124 to $122.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 13 ’25 when Pizzie Nick sold 12,000 shares for $129.86 per share. The transaction valued at 1,558,320 led to the insider holds 42,187 shares of the business.
Pizzie Nick sold 3,000 shares of AXSM for $393,210 on Feb 14 ’25. The Chief Financial Officer now owns 42,187 shares after completing the transaction at $131.07 per share. On Feb 14 ’25, another insider, Pizzie Nick, who serves as the Officer of the company, bought 3,000 shares for $131.07 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXSM now has a Market Capitalization of 4664410624 and an Enterprise Value of 4698549760. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.09 while its Price-to-Book (P/B) ratio in mrq is 81.65. Its current Enterprise Value per Revenue stands at 12.182 whereas that against EBITDA is -19.219.
Stock Price History:
The Beta on a monthly basis for AXSM is 0.49, which has changed by 0.38322484 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, AXSM has reached a high of $139.13, while it has fallen to a 52-week low of $64.11. The 50-Day Moving Average of the stock is -20.06%, while the 200-Day Moving Average is calculated to be -1.62%.
Shares Statistics:
The stock has traded on average 957.83K shares per day over the past 3-months and 1106030 shares per day over the last 10 days, according to various share statistics. A total of 48.67M shares are outstanding, with a floating share count of 40.08M. Insiders hold about 17.82% of the company’s shares, while institutions hold 77.66% stake in the company. Shares short for AXSM as of 1741910400 were 4905057 with a Short Ratio of 5.37, compared to 1739491200 on 5867051. Therefore, it implies a Short% of Shares Outstanding of 4905057 and a Short% of Float of 12.0299995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
